Reliance Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 12-07-2024
- Paid Up Capital ₹ 2.70 M
as on 12-07-2024
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.42 Cr
as on 12-07-2024
- Satisfied Charges ₹ 3.07 Cr
as on 12-07-2024
- Revenue 19.28%
(FY 2020)
- Profit 35.94%
(FY 2020)
- Ebitda -7.88%
(FY 2020)
- Net Worth 41.67%
(FY 2020)
- Total Assets 8.67%
(FY 2020)
About Reliance Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.70 M.
The company currently has active open charges totaling ₹1.42 Cr. The company has closed loans amounting to ₹3.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raman Gupta, Sushma Gupta, and Anandita Gupta serve as directors at the Company.
- CIN/LLPIN
U24239PB1997PTC020694
- Company No.
020694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reliance Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushma Gupta  | Managing Director | 17-Sep-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anandita Gupta | Director | 03-May-2021 | Current |
| Raman Gupta | Whole-Time Director | 01-Jan-1999 | Current |
Financial Performance of Reliance Biotech.
Reliance Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.28% increase. The company also saw a substantial improvement in profitability, with a 35.94% increase in profit. The company's net worth Soared by an impressive increase of 41.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reliance Biotech?
In 2020, Reliance Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Dec 2023 | ₹3.50 M | Open |
Canara Bank Creation Date: 15 Feb 2021 | ₹0.70 M | Open |
Canara Bank Creation Date: 16 Oct 2006 | ₹1.00 Cr | Open |
How Many Employees Work at Reliance Biotech?
Unlock and access historical data on people associated with Reliance Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reliance Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reliance Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
